122 related articles for article (PubMed ID: 8836976)
1. Altered energy metabolism in Alzheimer's disease.
Ogawa M; Fukuyama H; Ouchi Y; Yamauchi H; Kimura J
J Neurol Sci; 1996 Jul; 139(1):78-82. PubMed ID: 8836976
[TBL] [Abstract][Full Text] [Related]
2. [Altered energy metabolism in Alzheimer's disease].
Ogawa M; Fukuyama H; Ouchi Y; Yamauchi H; Kimura J
Rinsho Shinkeigaku; 1994 Jan; 34(1):27-31. PubMed ID: 8156707
[TBL] [Abstract][Full Text] [Related]
3. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
[TBL] [Abstract][Full Text] [Related]
4. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
Ishii K; Sasaki M; Kitagaki H; Yamaji S; Sakamoto S; Matsuda K; Mori E
J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
[TBL] [Abstract][Full Text] [Related]
5. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
6. [Measurements of cerebral blood flow and metabolism in patients with Alzheimer's disease].
Kitamura S; Terashi A
Rinsho Byori; 1990 May; 38(5):494-8. PubMed ID: 2381074
[TBL] [Abstract][Full Text] [Related]
7. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
8. Changes in cerebral blood flow and oxygen metabolism related to magnetic resonance imaging white matter hyperintensities in Alzheimer's disease.
Yamaji S; Ishii K; Sasaki M; Imamura T; Kitagaki H; Sakamoto S; Mori E
J Nucl Med; 1997 Sep; 38(9):1471-4. PubMed ID: 9293811
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of SPECT in the study of Alzheimer's disease].
Blanco A; Alberca R; Marqués ; López Domínguez JM; Gil Néciga E; Carrizosa E
Neurologia; 1998 Feb; 13(2):63-8. PubMed ID: 9578672
[TBL] [Abstract][Full Text] [Related]
10. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.
Hertz L; Chen Y; Waagepetersen HS
J Neurochem; 2015 Jul; 134(1):7-20. PubMed ID: 25832906
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Alavi A; Newberg AB; Souder E; Berlin JA
J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
13. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography.
Salmon E; Gregoire MC; Delfiore G; Lemaire C; Degueldre C; Franck G; Comar D
J Cereb Blood Flow Metab; 1996 May; 16(3):399-408. PubMed ID: 8621744
[TBL] [Abstract][Full Text] [Related]
14. Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis.
Minoshima S; Frey KA; Foster NL; Kuhl DE
J Comput Assist Tomogr; 1995; 19(4):541-7. PubMed ID: 7622680
[TBL] [Abstract][Full Text] [Related]
15. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
16. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patients.
Blin J; Ivanoiu A; Coppens A; De Volder A; Labar D; Michel C; Laterre EC
Neuroimage; 1997 Nov; 6(4):335-43. PubMed ID: 9417975
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of glucose metabolism in Alzheimer's disease.
Hoyer S
Ann N Y Acad Sci; 1991; 640():53-8. PubMed ID: 1776759
[TBL] [Abstract][Full Text] [Related]
19. A SPECT study of parkinsonism in Alzheimer's disease.
Starkstein SE; Vazquez S; Merello M; Tesón A; Petracchi M; Leiguarda R
J Neuropsychiatry Clin Neurosci; 1995; 7(3):308-13. PubMed ID: 7580189
[TBL] [Abstract][Full Text] [Related]
20. Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia.
Hasselbalch SG; Madsen PL; Hageman LP; Olsen KS; Justesen N; Holm S; Paulson OB
Am J Physiol; 1996 May; 270(5 Pt 1):E746-51. PubMed ID: 8967461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
